The arrival of Tirzepatide at a 45mg strength represents a significant advance in treating type 2 diabetes. Until recently, smaller doses were usually administered, but this latest formulation offers the potential for more effective glucose control in some individuals. Doctors are evaluating its effectiveness and security profile, especially in ind